Thursday, May 13, 2021 |
Baltimore
70°
Partly Cloudy
FOLLOW US:

Pay for CEO of Emergent BioSolutions, maker of COVID vaccine in Baltimore, increased 51% in 2020

April 13, 2021

The president and CEO of Emergent BioSolutions, a Gaithersburg-based maker of the Johnson & Johnson COVID vaccine at a troubled East Baltimore plant, saw his compensation grow 51% last year. Robert Kramer, 63, who has led Emergent BioSolutions since April 2019, earned $5.6 million in 2020, up from $3.7 million in total pay in 2019, according to a filing with the U.S. Securities and Exchange Commission. After a mix-up at its East Baltimore manufacturing plant near the Johns Hopkins Bayview Medical Center ruined about 15 million doses of Johnson & Johnson’s vaccine, the federal government gave the New Jersey-based drug company control of the Emergent BioSolutions facility. The plant, built with federal funds for responding biothreats to the nation, has not yet received emergency use authorization from the federal government.

Article Source: Baltimore Sun

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.